NOS3 and cancer: Thus, the inhibition of eNOS may act as a therapeutic strategy to inhibit cancer progression, potentially via the use of Nω‐nitro‐l‐arginine methyl ester hydrochloride (l‐NAME), an l‐arginine analogue that is an eNOS inhibitor.